AGLagilon health, inc.

NYSE agilonhealth.com


$ 4.07 $ -0.08 (-1.92 %)    

Friday, 30-Aug-2024 15:59:59 EDT
QQQ $ 476.00 $ 5.61 (1.19 %)
DIA $ 416.44 $ 2.30 (0.56 %)
SPY $ 563.62 $ 5.33 (0.95 %)
TLT $ 96.60 $ -1.04 (-1.07 %)
GLD $ 231.30 $ -1.66 (-0.71 %)
$ 4.08
$ 4.07 x 1,398
$ 4.08 x 1,400
-- - --
$ 4.03 - $ 20.37
3,130,306
na
1.68B
$ 0.67
nm
TBD
na
na ($ 0.00)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
1 08-06-2024 06-30-2024 10-Q
2 05-07-2024 03-31-2024 10-Q
3 02-27-2024 12-31-2023 10-K
4 11-02-2023 09-30-2023 10-Q
5 08-03-2023 06-30-2023 10-Q
6 05-09-2023 03-31-2023 10-Q
7 03-01-2023 12-31-2022 10-K
8 11-03-2022 09-30-2022 10-Q
9 08-04-2022 06-30-2022 10-Q
10 05-05-2022 03-31-2022 10-Q
11 03-03-2022 12-31-2021 10-K
12 10-28-2021 09-30-2021 10-Q
13 08-04-2021 06-30-2021 10-Q
14 05-26-2021 03-31-2021 10-Q
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

 deutsche-bank-maintains-hold-on-agilon-health-lowers-price-target-to-4

Deutsche Bank analyst George Hill maintains Agilon Health (NYSE:AGL) with a Hold and lowers the price target from $5 to $4.

 benchmark-reiterates-buy-on-agilon-health-maintains-9-price-target

Benchmark analyst Bill Sutherland reiterates Agilon Health (NYSE:AGL) with a Buy and maintains $9 price target.

 rbc-capital-reiterates-outperform-on-agilon-health-maintains-8-price-target

RBC Capital analyst Sean Dodge reiterates Agilon Health (NYSE:AGL) with a Outperform and maintains $8 price target.

 agilon-health-q2-sales-1483b-miss-1560b-estimate

Agilon Health (NYSE:AGL) reported quarterly sales of $1.483 billion which missed the analyst consensus estimate of $1.560 billi...

 evercore-isi-group-maintains-in-line-on-agilon-health-raises-price-target-to-7

Evercore ISI Group analyst Elizabeth Anderson maintains Agilon Health (NYSE:AGL) with a In-Line and raises the price target ...

 agilon-health-appoints-jeff-schwaneke-as-new-cfo--effective-july-1-2024

agilon health, inc. (NYSE:AGL), the trusted partner empowering physicians to transform health care in our communities, announce...

 baird-initiates-coverage-on-agilon-health-with-neutral-rating-announces-price-target-of-6

Baird analyst Michael Halloran initiates coverage on Agilon Health (NYSE:AGL) with a Neutral rating and announces Price Targ...

 truist-securities-maintains-hold-on-agilon-health-raises-price-target-to-65

Truist Securities analyst Jailendra Singh maintains Agilon Health (NYSE:AGL) with a Hold and raises the price target from $6...

 agilon-health-q1-2024-gaap-eps-001-beats-001-estimate-sales-1604b-inline

Agilon Health (NYSE:AGL) reported quarterly earnings of $0.01 per share which beat the analyst consensus estimate of $(0.01) by...

 stifel-maintains-hold-on-agilon-health-lowers-price-target-to-7

Stifel analyst Craig Jones maintains Agilon Health (NYSE:AGL) with a Hold and lowers the price target from $8 to $7.

 citigroup-initiates-coverage-on-agilon-health-with-neutral-rating-announces-price-target-of-6

Citigroup analyst Daniel Grosslight initiates coverage on Agilon Health (NYSE:AGL) with a Neutral rating and announces Price...

 why-stryve-foods-shares-are-trading-lower-by-around-25-here-are-other-stocks-moving-in-tuesdays-mid-day-session

Shares of Stryve Foods, Inc. (NASDAQ: SNAX) fell sharply during Tuesday’s session following a fourth-quarter revenue miss.

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION